Treatment of distal deep vein thrombosis

G Kirkilesis, SK Kakkos, C Bicknell… - Cochrane Database …, 2020 - cochranelibrary.com
Background The treatment of distal (below the knee) deep vein thrombosis (DVT) is not
clearly established. Distal DVT can either be treated with anticoagulation, or monitored with …

Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis

C Brown, W Brandt, TF Wang, A Delluc, M Carrier - Thrombosis Research, 2023 - Elsevier
Background Isolated distal deep vein thrombosis (IDDVT) is a common clinical presentation
of DVT. The efficacy and safety of anticoagulant therapy for the management of IDDVT in …

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial

W Ageno, L Bertù, E Bucherini, G Camporese… - bmj, 2022 - bmj.com
Objective To compare two different treatment durations of rivaroxaban in patients with
symptomatic isolated distal deep vein thrombosis (DVT). Design Randomised, double blind …

[HTML][HTML] Isolated distal deep vein thrombosis: perspectives from the GARFIELD-VTE registry

SM Schellong, SZ Goldhaber, JI Weitz… - Thrombosis and …, 2019 - thieme-connect.com
Isolated distal deep vein thrombosis (IDDVT) represents up to half of all lower limb DVT. This
study investigated treatment patterns and outcomes in 2,145 patients with IDDVT in …

Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital

CT Jørgensen, M Tavoly, E Førsund… - Journal of Thrombosis …, 2023 - Elsevier
Background Isolated distal deep vein thrombosis (IDDVT) is a common presentation of deep
vein thrombosis. There are limited data on the long-term risk of recurrence after IDDVT …

[HTML][HTML] Current trends in the duration of anticoagulant therapy for venous thromboembolism: a systematic review

P Alexander, S Visagan, R Issa, VR Gorantla… - Cureus, 2021 - ncbi.nlm.nih.gov
Anticoagulation therapy is the first line and drug of choice for both the treatment and
prophylaxis of venous thromboembolism (deep vein thrombosis and/or pulmonary …

Venous thromboembolism: A clinician update

M Serhal, GD Barnes - Vascular Medicine, 2019 - journals.sagepub.com
Venous thromboembolism (VTE) is a common vascular condition. New medications are
available to prevent hospital-associated VTE. Strategies are being studied to increase …

[HTML][HTML] Isolated calf deep venous thrombosis: frequency on venous ultrasound and clinical characteristics

T Heller, M Becher, JC Kröger, E Beller, S Heller… - BMC Emergency …, 2021 - Springer
Background It remains controversial whether to include calf veins in the initial ultrasound
evaluation of suspected deep venous thrombosis (DVT). We sought to investigate the …

[HTML][HTML] Patient management strategies and long-term outcomes in isolated distal deep-vein thrombosis versus proximal deep-vein thrombosis: findings from XALIA

W Ageno, LG Mantovani, S Haas, R Kreutz, D Monje… - TH Open, 2019 - thieme-connect.com
Background Overall, 30 to 50% of lower-limb deep-vein thrombosis (DVT) cases are isolated
distal DVT (IDDVT). The recurrent venous thromboembolism (VTE) risk is unclear, leaving …

[HTML][HTML] Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis

DT Vlazny, AK Pasha, W Kuczmik… - Journal of Thrombosis …, 2021 - Elsevier
Background Isolated, distal deep vein thrombosis (IDDVT) is thought to have low rates of
propagation, embolization, and recurrence compared with proximal DVT (PDVT), but the …